BRACANALYSIS CDX
FDA premarket approval P140020/S001 · decided 2016-04-29
Approval details
- PMA number
- P140020
- Supplement
- S001
- Supplement type
- Real-Time Process
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- BRACANALYSIS CDX
- Generic name
- Cancer-related germline gene mutation detection system
- Applicant
- Myriad Genetic Laboratories
- Date received
- 2015-06-19
- Decision date
- 2016-04-29
- Days to decision
- 315 days
- Decision code
- APPR
- Product code
- PJG
- Advisory committee
- Pathology
- Expedited review
- No
- Location
- Salt Lake Cit, UT
- Statement
- Approval to add additional critical instruments of the same type using approved protocols.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.